Differentiating celiac disease from other diseases: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 48: Line 48:
|
|
* [[Gluten-free diet]]
* [[Gluten-free diet]]
* Signs of the fat-soluble [[Vitamin A|vitamins A]], [[Vitamin D|D]], E, and K deficiency
* Signs of the fat-soluble [[Vitamin A|vitamins A]], [[Vitamin D|D]], [[Vitamin E|E]], and [[Vitamin K|K]] deficiency
|
|
* [[HLA]]-DQ2 and/or DQ8 [[gene mutation]]  
* [[HLA]]-DQ2 and/or DQ8 [[gene mutation]]  
* Innate responses to [[wheat proteins]]
* Innate responses to [[wheat proteins]]
|
|
* [[Immunoglobulin A]] (IgA) anti-tissue transglutaminase (TTG) antibody
* [[Immunoglobulin A]] (IgA) [[Tissue transglutaminase|anti-tissue transglutaminase]] (TTG) antibody
|-
|-
! align="center" style="background:#DCDCDC;" |Grain allergy
! align="center" style="background:#DCDCDC;" |Grain allergy
Line 96: Line 96:
** [[Infertility]]
** [[Infertility]]
|
|
* Mutations in the [[cystic fibrosis]] transmembrane conductance regulator (CFTR) protein
* Mutations in the [[cystic fibrosis transmembrane conductance regulator]] ([[CFTR]]) protein
|
|
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L
Line 111: Line 111:
|
|
* Stool [[osmotic]] gap of >125 mOsm/kg 
* Stool [[osmotic]] gap of >125 mOsm/kg 
* Stool pH <6 
* Stool [[pH]] <6 
|
|
* Avoidance of [[Dietary|dietary]]<nowiki/> [[lactose]]
* Avoidance of [[Dietary|dietary]]<nowiki/> [[lactose]]
* Substitution to maintain [[nutrient]] intake
* Maintenance of [[nutrient]] intake
* Regulation of [[calcium]] intake
* Regulation of [[calcium]] intake
* Use of [[enzyme]] [[lactase]]
* Use of [[enzyme]] [[lactase]]
Line 120: Line 120:
* Acquired primary [[lactase deficiency]]
* Acquired primary [[lactase deficiency]]
** Adult-type [[hypolactasia]]
** Adult-type [[hypolactasia]]
** [[Lactase]] nonpersistence)
** Inability to produce persistent[[Lactase]]  
|
|
* [[Lactose]] breath hydrogen test
* [[Hydrogen Breath Test|Lactose breath hydrogen test]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]]
! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]]
Line 171: Line 171:
|
|
* [[Laxatives|Laxative]] screening on a stool for:
* [[Laxatives|Laxative]] screening on a stool for:
** [[Diphenolic laxatives]] (eg, [[bisacodyl]])
** [[Laxatives|Diphenolic laxatives]] (eg, [[bisacodyl]])
** [[Polyethylene glycol|Polyethylene glyco]]<nowiki/>l-containing [[laxatives]]
** [[Polyethylene glycol|Polyethylene glyco]]<nowiki/>l-containing [[laxatives]]
|-
|-
Line 197: Line 197:
* [[Graves' disease]]
* [[Graves' disease]]
* [[Hashimoto's thyroiditis|Hashimoto thyroiditis]]
* [[Hashimoto's thyroiditis|Hashimoto thyroiditis]]
* Toxic adenoma  
* [[Toxic Adenoma|Toxic adenoma]]
|
|
* [[TSH]]  
* [[TSH]]  
Line 238: Line 238:
|
|
* Postinfectious
* Postinfectious
* Inflammatory
* [[Inflammatory]]
|
|
* [[Diagnosis|Clinical diagnosis]]
* [[Diagnosis|Clinical diagnosis]]
Line 312: Line 312:
* Symptoms begin mainly after ingestion of [[lactose]]
* Symptoms begin mainly after ingestion of [[lactose]]
|
|
* Reduction of lactase enzyme activity or lactase nonpersistence
* Reduction of lactase enzyme activity or in ability to produce persistent [[lactase]]
* Congenital lactase deficiency
* Congenital [[lactase deficiency]]
|
|
* Lactase activity assay
* [[Lactase]] activity assay
|-
|-
! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES)
! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES)
Line 332: Line 332:
* [[Polymorphonuclear leukocytes]] presence
* [[Polymorphonuclear leukocytes]] presence
|
|
* Triggered by cow's milk protein
* Triggered by cow milk protein
* Profuse, repetitive [[vomiting]]
* Profuse, repetitive [[vomiting]]
|
|
Line 490: Line 490:
* Symptomatic as long as the diet includes [[lactose]] or its [[hydrolysis]] products, [[glucose]] and [[galactose]]
* Symptomatic as long as the diet includes [[lactose]] or its [[hydrolysis]] products, [[glucose]] and [[galactose]]
|
|
* Mutations in solute carrier family 5, member 1 gene (''SLC5A1'', also known as ''SGLT1'')
* Mutations in solute carrier family 5, member 1 gene (''[[SLC5A1]]'', also known as ''[[SGLT1]]'')
** Lead to deficiency in the intestinal sodium/glucose transporter
** Lead to deficiency in the intestinal sodium/glucose transporter
|
|

Revision as of 15:26, 13 September 2017

Celiac disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Celiac disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Life Style Modifications
Pharmacotherapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Differentiating celiac disease from other diseases On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Differentiating celiac disease from other diseases

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Differentiating celiac disease from other diseases

CDC on Differentiating celiac disease from other diseases

Differentiating celiac disease from other diseases in the news

Blogs onDifferentiating celiac disease from other diseases

Directions to Hospitals Treating Celiac disease

Risk calculators and risk factors for Differentiating celiac disease from other diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Celiac disease must be differentiated from other diseases presenting as chronic diarrhea. Common differentials of celiac disease include lactose intolerance, cystic fibrosis, Crohns disease, laxative overuse, hyperthyroidism and irritable bowel syndrome.

Differentiating Celiac Disease from Other Diseases

Celiac disease must be differentiated from other diseases presenting as chronic diarrhea (diarrhea for more than 2 weeks) and abdominal pain and discomfort. The table below summarizes the findings that differentiate causes of chronic diarrhea and abdominal pain:[1][2][3][4][5][6][7]

Cause Diarrhea Peak age of onset History Physical exam Lab findings Additional finding Cause/Pathogenesis Gold standard dignosis
Watery Fatty Weight loss FTT Abdominal pain
Celiac disease +/- +/- Childhood

Adult

+ + +
Grain allergy + - Childhood + + +
Cystic fibrosis - + Infancy and childhood + + +
  • Positive DNA analysis for CFTR multimutation method
  • Evaluated nasal transepithelial potential difference (NPD)
Lactose intolerance + - Adult - - +
  • Stool osmotic gap of >125 mOsm/kg 
  • Stool pH <6 
Crohns disease + - Young adults

(20th)

+ +/- +
  • Abnormal immune response to self antigens
Laxative overuse + - After childhood +/- - +/- -
Hyperthyroidism + - Any age + - +/-
  • Elevated T4
  • Elevated T3
  • Decreased level of TSH
Whipple disease +/- + 50th + - +
Irritable bowel syndrome + - Between 30 and 50 - - + -
VIPoma + - Between 30 and 50 + +/- +/-
  • Primary secretory tumor
  • Elevated VIP levels
  • Followed by imaging
Gastrinoma (Zollinger-Ellison syndrome) + - Between the ages of 20 and 50 + +/- +
  • Elevated basal or stimulated serum gastrin more than 1000 pg/mL
Lactose intolerance - + Any age + - +/-
Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) + - Infancy +/- +/- + Stool examination:
  • Triggered by cow milk protein
  • Profuse, repetitive vomiting
  • Oral food challenge (OFC)
Eosinophilic gastroenteritis  + - 30th +/- +/- +
Primary bile acid malabsorption + +/- Childhood Adolescents + + +/- -
Abetalipoproteinemia - + Infancy + + +
Microscopic colitis + - 60th + - +
Congenital chloride diarrhea + - Neonate + + - -

Mutations in the SLC26A3 gene

Congenital sodium diarrhea + - Neonate + + - - Stool examination:

Serum:

  • Mutations in the SPINT2 gene
Clinical
Glucose-galactose malabsorption + - Infancy + +/- + Stool examination:
  • Acidic
  • Mutations in solute carrier family 5, member 1 gene (SLC5A1, also known as SGLT1)
    • Lead to deficiency in the intestinal sodium/glucose transporter

References

  1. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
  2. Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
  3. Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
  4. RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.
  5. Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
  6. Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
  7. BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.

Template:WH Template:WS